-
Suneva Medical Inc., San Diego, Calif. Product: ArteFill Business: Dermatology Molecular target: Not available Description: Polymethylmethacrylate (PMMA) microspheres suspended in ultra-purified U.S. bovine collagen …
Published on 5/20/2013
-
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Fasiglifam (TAK-875) Business: Endocrine/Metabolic Molecular target: Free fatty acid receptor 1 (FFAR1) (GPR40) Description: Free fatty acid receptor 1…
Published on 5/20/2013
-
Hisamitsu Pharmaceutical Co. Inc. (Tokyo:4530; Osaka:4530), Tosu, Japan Product: HTU-520 Business: Infectious Molecular target: NA Description: Terbinafine hydrochloride patch Indication: Treat onychomycosis Endpoint: …
Published on 5/20/2013
-
Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Product: Idelalisib (formerly CAL-101, GS 1101, GS-1101) Business: Cancer Molecular target: Phosphoinositide 3-kinase (PI3K) delta Description: Small molecule …
Published on 5/20/2013
-
ThromboGenics N.V. (Euronext:THR), Leuven, Belgium Product: Jetrea ocriplasmin (formerly Microplasmin) Business: Ophthalmic Molecular target: Not applicable Description: Recombinant microplasmin, a truncated form of the…
Published on 5/20/2013
-
Genentech Inc., South San Francisco, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: MPDL3280A, RG7446 Business: Cancer Molecular target: Programmed cell death 1 ligand 1 (CD274 molecule) (PD-L1) (B7-H1…
Published on 5/20/2013
-
Celsus Therapeutics plc (OTCQB:MRRBY), London, U.K. Product: MRX-6, MRX6 Business: Dermatology Molecular target: Phospholipase A2 (PLA2) Description: Topical multifunctional anti-inflammatory compound that inhibits …
Published on 5/20/2013
-
Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Product: N9-GP, pegylated recombinant human Factor IX (PEG-rFIX) Business: Hematology Molecular target: Factor IX Description: Glyco-pegylated derivative of …
Published on 5/20/2013
-
Helsinn Healthcare S.A., Pazzallo-Lugano, Switzerland IS Pharma plc (LSE:ISPH), Chester, U.K. Taiho Pharmaceutical Co. Ltd., Tokyo, Japan Product: NEPA (Netu-palo-FDC) Business: Gastrointestinal Molecular target: …
Published on 5/20/2013
-
Boehringer Ingelheim GmbH, Ingelheim, Germany Product: Nintedanib (Vargatef) (BIBF 1120) Business: Cancer Molecular target: Vascular endothelial growth factor (VEGF) receptor; Platelet derived growth factor receptor (…
Published on 5/20/2013
-
Tesaro Inc. (NASDAQ:TSRO), Waltham, Mass. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Product: Niraparib (formerly MK-4827) Business: Cancer Molecular target: Poly(ADP-ribose) polymerase (PARP) Description: …
Published on 5/20/2013
-
Ono Pharmaceutical Co. Ltd. (Tokyo:4528; Osaka:4528), Osaka, Japan Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Product: Nivolumab (ONO-4538, MDX-1106, BMS-936558) Business: Cancer Molecular target: PD-1 receptor…
Published on 5/20/2013
-
Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Genentech Inc., South San Francisco, Calif. Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Nippon Shinyaku Co. Ltd. (Tokyo:4516; Osaka:4516), Kyoto, Japan Roche (…
Published on 5/20/2013
-
Genomic Health Inc. (NASDAQ:GHDX), Redwood City, Calif. Product: Oncotype DX prostate cancer assay Business: Diagnostic Molecular target: NA Description: Prostate biopsy test that measures the expression of 17 genes to …
Published on 5/20/2013
-
Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Product: PEGPH20 (formerly PEGrHuPH20) Business: Cancer Molecular target: Hyaluronan Description: Recombinant human PH20 hyaluronidase enzyme conjugated to …
Published on 5/20/2013
-
Oncothyreon Inc. (NASDAQ:ONTY), Seattle, Wash. Product: PX-866 Business: Cancer Molecular target: Phosphoinositide 3-kinase (PI3K) Description: Oral phosphoinositide 3-kinase (PI3K) inhibitor Indication: Treat recurrent…
Published on 5/20/2013
-
Oncothyreon Inc. (NASDAQ:ONTY), Seattle, Wash. Product: PX-866 Business: Cancer Molecular target: Phosphoinositide 3-kinase (PI3K) Description: Oral phosphoinositide 3-kinase (PI3K) inhibitor Indication: Treat recurrent…
Published on 5/20/2013
-
Bharat Biotech International Ltd., Hyderabad, India Product: Rotavac (ORV 116E) Business: Infectious Molecular target: NA Description: Live attenuated 116E rotavirus monovalent vaccine Indication: Prevent rotavirus …
Published on 5/20/2013
-
Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Product: SAR302503 (formerly TG101348) Business: Hematology Molecular target: Janus kinase-2 (JAK-2) Description: Selective oral Janus kinase-2 (JAK-2) inhibitor Indication…
Published on 5/20/2013
-
Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Product: Yervoy ipilimumab (BMS-734016) Business: Cancer Molecular target: CTLA-4 (CD152) Description: Human mAb against CTLA-4 receptor Indication: Treat unresectable…
Published on 5/20/2013
-
Viralytics Ltd. (ASX:VLA), Pymble, Australia Product: Cavatak Business: Cancer Molecular target: Intercellular adhesion molecule-1 (ICAM-1) (CD54) Description: Coxsackievirus A21 (CVA21) Indication: Treat solid tumors …
Published on 4/15/2013
-
Photocure ASA (OSE:PHO), Oslo, Norway Product: Cevira Business: Cancer Molecular target: NA Description: Photodynamic therapy (PDT) combining hexaminolevulinate (HAL) with illumination by a red light source Indication: …
Published on 4/15/2013
-
Prosensa B.V., Leiden, the Netherlands GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Drisapersen (PRO051, GSK2402968) Business: Musculoskeletal Molecular target: NA Description: Antisense …
Published on 4/15/2013
-
VG Life Sciences Inc. (Pink:VGLS), San Marino, Calif. Product: Hydroxychloroquine Business: Cancer Molecular target: NA Description: Hydroxychloroquine developed using Metabolic Disruption Technology (MDT) Indication: …
Published on 4/15/2013
-
Transgene S.A. (Euronext:TNG), Illkirch, France Product: MVA-HCV (TG4040) Business: Infectious Molecular target: Not applicable Description: Recombinant modified vaccinia Ankara (MVA) virus vector containing nucleotide …
Published on 4/15/2013